<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39432758</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1938-3673</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>21</Day></PubDate></JournalIssue><Title>Journal of leukocyte biology</Title><ISOAbbreviation>J Leukoc Biol</ISOAbbreviation></Journal><ArticleTitle>Machine learning algorithm approach to complete blood count can be used as early predictor of COVID-19 outcome.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">qiae223</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/jleuko/qiae223</ELocationID><Abstract><AbstractText>Although the SARS-CoV-2 infection has established risk groups, identifying biomarkers for disease outcomes is still crucial to stratify patient risk and enhance clinical management. Optimal efficacy of COVID-19 antiviral medications relies on early administration within the initial five days of symptoms, assisting high-risk patients in avoiding hospitalization and improving survival chances. The complete blood count can be an efficient and affordable option to find biomarkers that predict the COVID-19 prognosis due to infection-induced alterations in various blood parameters. This study aimed to associate hematological parameters with different COVID-19 clinical forms and utilize them as disease outcome predictors. We performed a complete blood count in blood samples from 297 individuals with COVID-19 from Belo Horizonte, Brazil. Statistical analysis, as well as ROC Curves and machine learning Decision Tree algorithms were used to identify correlations, and their accuracy, between blood parameters and disease severity. In the initial four days of infection, traditional hematological COVID-19 alterations, such as lymphopenia, were not yet apparent. However, the monocyte percentage and granulocyte-to-lymphocyte ratio proved to be reliable predictors for hospitalization, even in cases where patients exhibited mild symptoms that later progressed to hospitalization. Thus, our findings demonstrate that COVID-19 patients with monocyte percentages lower than 7.7% and a granulocyte-to-lymphocyte ratio higher than 8.75 are assigned to the hospitalized group with a precision of 86%. This suggests that these variables can serve as important biomarkers in predicting disease outcomes and could be used to differentiate patients at hospital admission for managing therapeutic interventions, including early antiviral administration. Moreover, they are simple parameters that can be useful in minimally equipped health care units.</AbstractText><CopyrightInformation>© The Author(s) 2024. Published by Oxford University Press on behalf of Society for Leukocyte Biology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ramalho-Pinto</LastName><ForeName>Cecília Horta</ForeName><Initials>CH</Initials><Identifier Source="ORCID">0000-0002-0499-620X</Identifier><AffiliationInfo><Affiliation>Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ventura</LastName><ForeName>Lucas Haniel de Araújo</ForeName><Initials>LHA</Initials><Identifier Source="ORCID">0000-0002-3579-6833</Identifier><AffiliationInfo><Affiliation>Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camatta</LastName><ForeName>Giovanna Caliman</ForeName><Initials>GC</Initials><Identifier Source="ORCID">0000-0001-8278-773X</Identifier><AffiliationInfo><Affiliation>Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silveira-Nunes</LastName><ForeName>Gabriela</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-0557-2177</Identifier><AffiliationInfo><Affiliation>Departamento de Medicina, Universidade Federal de Juiz de Fora, Governador Valadares, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomes</LastName><ForeName>Matheus de Souza</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Instituto de Biotecnologia, Universidade Federal de Uberlândia, Patos de Minas, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sato</LastName><ForeName>Hugo Itaru</ForeName><Initials>HI</Initials><Identifier Source="ORCID">0000-0001-5180-9983</Identifier><AffiliationInfo><Affiliation>Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>Murilo Soares</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Departamento de Clínica Médica, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guimarães</LastName><ForeName>Henrique Cerqueira</ForeName><Initials>HC</Initials><Identifier Source="ORCID">0000-0002-6680-7099</Identifier><AffiliationInfo><Affiliation>Hospital Universitário Risoleta Tolentino Neves, Belo Horizonte, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbuto</LastName><ForeName>Rafael Calvão</ForeName><Initials>RC</Initials><Identifier Source="ORCID">0000-0001-6488-734X</Identifier><AffiliationInfo><Affiliation>Hospital Universitário Risoleta Tolentino Neves, Belo Horizonte, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filho</LastName><ForeName>Olindo Assis Martins</ForeName><Initials>OAM</Initials><AffiliationInfo><Affiliation>Instituto de Pesquisa René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>do Amaral</LastName><ForeName>Laurence Rodrigues</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>Faculdade de Computação, Universidade Federal de Uberlândia, Patos de Minas, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertarini</LastName><ForeName>Pedro Luiz Lima</ForeName><Initials>PLL</Initials><AffiliationInfo><Affiliation>Faculdade de Engenharia Elétrica, Universidade Federal de Uberlândia, Patos de Minas, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teixeira</LastName><ForeName>Santuza Maria Ribeiro</ForeName><Initials>SMR</Initials><Identifier Source="ORCID">0000-0002-2588-2842</Identifier><AffiliationInfo><Affiliation>Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tupinambás</LastName><ForeName>Unaí</ForeName><Initials>U</Initials><Identifier Source="ORCID">0000-0001-6833-3870</Identifier><AffiliationInfo><Affiliation>Departamento de Medicina, Universidade Federal de Juiz de Fora, Governador Valadares, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teixeira Carvalho</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2814-5183</Identifier><AffiliationInfo><Affiliation>Instituto de Pesquisa René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faria</LastName><ForeName>Ana Maria Caetano</ForeName><Initials>AMC</Initials><Identifier Source="ORCID">0000-0002-0604-8510</Identifier><AffiliationInfo><Affiliation>Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Leukoc Biol</MedlineTA><NlmUniqueID>8405628</NlmUniqueID><ISSNLinking>0741-5400</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Complete Blood Count</Keyword><Keyword MajorTopicYN="N">Machine Learning</Keyword><Keyword MajorTopicYN="N">Monocytes and GLR</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>22</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>22</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>14</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39432758</ArticleId><ArticleId IdType="doi">10.1093/jleuko/qiae223</ArticleId><ArticleId IdType="pii">7829172</ArticleId></ArticleIdList></PubmedData></PubmedArticle>